• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

gene mutation

Research

Amish-linked gene variant reduces risk of heart disease

A genetic variant linked to Old Order Amish people that reduces LDL cholesterol and a blood clotting protein could inform new heart disease therapies.
Kyle LaHucik Dec 6, 2021 8:50am

Vanderbilt team offers new clues for targeting p53

Sep 1, 2021 9:50am

Illumina CEO says U.S. behind on COVID-19 surveillance: CNBC

Jan 22, 2021 12:16pm

ESMO: Blueprint preps trial of drug for triple-mutant NSCLC

Sep 21, 2020 9:25am

Outsmarting COVID-19 by analyzing RNA in single cells

Aug 21, 2020 9:20am

Could the anti-cancer gene p53 be a target in kidney cancer?

Dec 20, 2019 9:42am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy